A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)
Clinical trial NCT01026142 · COMPLETED
Trial details
- NCT number
- NCT01026142
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-26
- Primary completion
- 2015-05-29
- Enrollment
- 452
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.